Over 40 Years' Experience, our purpose has remained the same — to create better and more affordable in-vitro diagnostics that are accessible to everyone. Started out in the immunoassay (CLIA/ELISA) and molecular diagnostic segments and expanded to Point of Care, Circular Tumour Cell segments and CDMO business. Our in-vitro diagnostic test portfolio including respiratory infections, blood virology, women’s and sexual health, oncology and human genetics and emerging infectious diseases, and equipment are now the trusted solution for hospital professionals, lab technicians, blood banks, and consumers worldwide. We further added clinical services and drug development business as part of our healthcare solution for our customers. We want to make a difference!
gbc.com.tw